Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2018
Price : $35 *
At a glance
- Drugs Palbociclib (Primary)
- Indications Carcinoma; Early breast cancer; Male breast cancer
- Focus Therapeutic Use
- 09 Oct 2018 Status changed from not yet recruiting to recruiting.
- 14 Sep 2018 Planned initiation date changed from 31 Jul 2018 to 31 Oct 2018.
- 27 Jun 2018 Planned initiation date changed from 4 Jun 2018 to 31 Jul 2018.